Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN)

19 filings reported holding LPCN - Lipocine Inc. - Common Stock, par value $0.0001 per share as of Q3 2024.
Lipocine Inc. - Common Stock, par value $0.0001 per share (LPCN) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 544,524 shares of 5,555,556 outstanding shares and own 9.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (221,459 shares), BlackRock, Inc. (89,272 shares), UBS Group AG (59,413 shares), GEODE CAPITAL MANAGEMENT, LLC (54,216 shares), RENAISSANCE TECHNOLOGIES LLC (40,332 shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (25,008 shares), STATE STREET CORP (18,626 shares), DIMENSIONAL FUND ADVISORS LP (18,016 shares), NORTHERN TRUST CORP (13,160 shares), and MORGAN STANLEY (2,634 shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.